Dr. Christophe Echeverri (Lead Founder, CEO/CSO): Dr. Echeverri's training as a molecular and cell biologist began at the University of Ottawa, studying cytoskeletal processes underlying mammalian neuronal differentiation and cell division. He then completed a PhD in Cell Biology (1998) at the University of Massachusetts in Worcester, focusing on the role of microtubule-based motors in a wide range of cellular processes. In 1998, he joined the laboratory of Dr. Anthony Hyman at the EMBL in Heidelberg, where, as a postdoctoral scientist, he co-directed the first genomic RNAi screening project with Dr. Pierre Gönczy. In 1999, Dr. Echeverri led the foundation of Cenix with Drs. Gönczy and Hyman as academic co-founders and Dr. Stefan Herr as business co-founder, and has since built up the company as its CEO/CSO from concept stage to its present profitability. Along the way, Dr. Echeverri was named one of the world's Top 100 Young Innovators in 2003 by MIT's Technology Review magazine, and emerged as a leading voice helping to drive the maturation of the RNAi screening field for both industry and academia.

Prof. Dr. Pierre Gönczy (Scientific co-founder): After studying biology at the University of Geneva, Pierre Gönczy obtained his Ph.D. in 1995 studying spermatogenesis in the Drosophila system at The Rockefeller University (New York, USA). During his post-doctoral work in the laboratory of Prof. Anthony Hyman at the EMBL (Heidelberg, Germany), he co-directed the genomic RNAi screening project with Dr. Echeverri, before leaving to establish his own research laboratory at the ISREC (Lausanne) as a senior scientist, where he remains today. In 2009 he was appointed as a full Professor in the School of Life Sciences at EPFL.
 
Prof. Dr. Anthony A. Hyman (Scientific co-founder): With over 70 publications in leading journals including Nature, Science and Cell, Prof. Hyman is a recognised world leader in the study of animal cell division, and particularly on the role of microtubule-based processes therein. He began this work during his Ph.D. in Biology/Zoology at Cambridge University, Kings College (1988), where he completed landmark research on the early stages of embryogenesis in C. elegans. He then turned to mammalian cells and in vitro systems during his post-doctoral work with Dr. Tim Mitchison at the Univ. of California-San Francisco (1988-1993), before expanding to the combined use of multiple experimental systems including yeast, C. elegans, Xenopus, and in vitro assays as a Group Leader at the EMBL (Heidelberg, 1993-1998). Since 1998, he continues this world leading research as a Group Leader and Director at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG, Dresden).  Prof. Hyman was awarded the EMBO Gold Medal in 2003, and the Leibniz prize in 2011.